See also this year's filing and all EDGAR filings for this company.
PDF Report 0001556263_2017_Syros_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001556263, Syros Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 85,508,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,850,000 |
| 3 | remainder_Assets | 965,000 |
| 4 | LiabilitiesCurrent | 9,567,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,463,000 |
| 9 | ResearchAndDevelopmentExpense | 37,817,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 537,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 91,323,000 |
| 1 | Liabilities | 9,567,000 |
| 2 | Expenses | 48,280,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 81,756,000 |
| 5 | NetIncome | -47,743,000 |
| 6 | ComprehensiveNetIncome | -47,743,000 |
| 7 | BaseVar | 74,853,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.59 |
| 9 | EconomicCapitalRatio | 3.41 |
Edgar->Model Mapping
Feature Distribution
